New PHARMAC funded cancer drugs already 'old and cheap', patient advocate Malcolm Mulholland says

Newshub

16 June 2022 - New cancer drugs that will now be funded by the Government drug buying agency are already considered "old and cheap", a patient advocate says.

PHARMAC has released its first round of funding for several cancer drugs and eight multiple sclerosis treatments. The list included a new treatment for use in early breast cancer and two rare leukaemia medicines.

Read Newshub article

Michael Wonder

Posted by:

Michael Wonder